Aquestive Therapeutics (AQST) Profit Margin (2017 - 2026)
Aquestive Therapeutics (AQST) profit margin from Jun 30, 2017 to Mar 31, 2026. The current Aquestive Therapeutics (AQST) profit margin is -55.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Aquestive Therapeutics (AQST)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -188.06% | +145.23% |
| 2024 | -76.69% | +392.85% |
| 2023 | -15.56% | -86.37% |
| 2022 | -114.11% | -17.77% |
| 2021 | -138.78% | +14.07% |
| 2020 | -121.66% | -3.39% |
| 2019 | -125.93% | -15.05% |
| 2019 | -148.23% | -19.40% |
| 2019 | -183.92% | +57.82% |
| 2019 | -116.53% | +28.02% |
| 2018 | -91.03% | -19.68% |
| 2018 | -113.34% | -56.73% |
| 2018 | -261.95% | -1595.69% |
| 2018 | 17.51% | -231.10% |
| 2017 | -13.36% | -142.92% |
| 2017 | 31.12% | -158.77% |
| 2017 | -52.96% | +496.37% |
| 2017 | -8.88% | N/A |
Comparison Aquestive Therapeutics (AQST) profit margin with competitors
Aquestive Therapeutics (AQST) profit margin is -55.78%.